title: [New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer].
authors.forename: Tomoharu
authors.initials: T
authors.lastname: Sugie
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Masakazu
authors.initials: M
authors.lastname: Toi
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D016692:Receptors, Antigen, T-Cell, gamma-delta; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D016692:Receptors, Antigen, T-Cell, gamma-delta; D000077211:Zoledronic Acid